Mutations in KEAP1 (Kelch-like ECH-associated protein 1) lead to activation of the Nrf2 (nuclear factor erythroid 2-related factor 2) pathway, thereby promoting tumor cell proliferation and survival (Fig. 2). Here, KEAP1 is linked to neoplasm.